Cargando…

Effects of Stem Cell Factor on Hypoxia-Inducible Factor 1 Alpha Accumulation in Human Acute Myeloid Leukaemia and LAD2 Mast Cells

Stem cell factor (SCF) is a hematopoietic growth factor that exerts its activity by signalling through the tyrosine kinase receptor known as Kit or CD117. SCF-Kit signalling is crucial for the survival, proliferation and differentiation of hematopoietic cells of myeloid lineage. Furthermore, since m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibbs, Bernhard F., Yasinska, Inna M., Oniku, Abraham E., Sumbayev, Vadim V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140519/ https://www.ncbi.nlm.nih.gov/pubmed/21799876 http://dx.doi.org/10.1371/journal.pone.0022502

Ejemplares similares

Involvement of Hypoxia-Inducible Factor-1 in the Inflammatory Responses of Human LAD2 Mast Cells and Basophils
por: Sumbayev, Vadim V., et al.
Publicado: (2012)

129 Involvement of the Hypoxia-Inducible Factor-1 Transcription Complex in the Inflammatory Responses of Human Mast Cells and Basophils
por: Yasinska, Inna, et al.
Publicado: (2012)

61 Hypoxia-Inducible Factor 1 (HIF-1) Transcription is a “Signalling Driver” for Allergic Inflammation, Host Innate Immune Defence and Leukaemia Progression
por: Sumbayev, Vadim, et al.
Publicado: (2012)

Alliance of galectin-3 and CD74 biochemical networks as a crucial component of survival machinery operated by human acute myeloid leukaemia cells
por: Yasinska, Inna M., et al.
Publicado: (2019)

Expression of functional neuronal receptor latrophilin 1 in human acute myeloid leukaemia cells
por: Sumbayev, Vadim V., et al.
Publicado: (2016)

Targeting of Basophil and Mast Cell Pro-Allergic Reactivity Using Functionalised Gold Nanoparticles
por: Yasinska, Inna M., et al.
Publicado: (2019)

Nitric Oxide Activates Apoptosis Signal - Regulating Kinase 1 (ASK 1) Forming S-Nitrosothiols with Reactive Thioredoxin SH-Groups. Nitric Oxide Synthase (NOS) Induction Mediated Inhibition of Poly-(ADP-RIBOSE)-Polymerase (PARP) and Protein Kinase C (PKC) Activities as well as Intranucleosomal DNA Fragmentation (IDF) Increase in the HEP-2 Cells
por: Sumbayev, Vadim V., et al.
Publicado: (2001)

Differential Role of Hypoxia-Inducible Factor 1 Alpha in Toll-Like Receptor-Mediated and Allergic Inflammatory Reactions
por: Sumbayev, Vadim V, et al.
Publicado: (2010)

High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression
por: Yasinska, Inna M., et al.
Publicado: (2018)

Mitochondrial Defunctionalization Supresses Tim-3-Galectin-9 Secretory Pathway in Human Colorectal Cancer Cells and Thus Can Possibly Affect Tumor Immune Escape
por: Sakhnevych, Svetlana S., et al.
Publicado: (2019)

Caffeine affects the biological responses of human hematopoietic cells of myeloid lineage via downregulation of the mTOR pathway and xanthine oxidase activity
por: Gibbs, Bernhard F., et al.
Publicado: (2015)

Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells
por: Selnø, Anette Teo Hansen, et al.
Publicado: (2020)

Platelet activating factor-induced mast cell degranulation is inhibited by rupatadine, and to a lower extent by levocetirizine and desoratadine, in a mast cell line (LAD-2)
por: Mullol, Joaquim, et al.
Publicado: (2013)

The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells
por: Gonçalves Silva, Isabel, et al.
Publicado: (2017)

MrgX2-mediated internalization of LL-37 and degranulation of human LAD2 mast cells
por: Murakami, Taisuke, et al.
Publicado: (2018)

T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins
por: Schlichtner, Stephanie, et al.
Publicado: (2023)

Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells
por: Silva, Isabel Gonçalves, et al.
Publicado: (2015)

Crucial involvement of xanthine oxidase in the intracellular signalling networks associated with human myeloid cell function
por: Abooali, Maryam, et al.
Publicado: (2014)

Expression of the Immune Checkpoint Protein VISTA Is Differentially Regulated by the TGF-β1 – Smad3 Signaling Pathway in Rapidly Proliferating Human Cells and T Lymphocytes
por: Schlichtner, Stephanie, et al.
Publicado: (2022)

Hypoxia. Hypoxia, hypoxia inducible factor and myeloid cell function
por: Walmsley, Sarah R, et al.
Publicado: (2009)

High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells
por: Teo Hansen Selnø, Anette, et al.
Publicado: (2021)

Comment on: Dual LAD with anomalous origin of long LAD from right coronary sinus: A variant of type VI LAD
por: Prasad, Abhishek, et al.
Publicado: (2017)

Activation of immune evasion machinery is a part of the process of malignant transformation of human cells
por: Abooali, Maryam, et al.
Publicado: (2023)

A Shropshire lad
por: Housman, A. E. (Alfred Edward), 1859-1936
Publicado: (1950)

A Keen Lad
Publicado: (1909)

Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia
por: Humphries, Sam, et al.
Publicado: (2023)

Isolation and characterisation of Kasumi-1 human myeloid leukaemia cell line resistant to tumour necrosis factor alpha-induced apoptosis.
por: Ido, M., et al.
Publicado: (1996)

Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive
por: Joris, Magalie, et al.
Publicado: (2012)

Monocytic myeloid‐derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib
por: Giallongo, Cesarina, et al.
Publicado: (2017)

Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells
por: Tomita, M., et al.
Publicado: (2011)

L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes
por: Schlichtner, Stephanie, et al.
Publicado: (2023)

Editorial: Pathological reactions of cytotoxic lymphoid cells as universal therapeutic targets in cancer and autoimmune disease
por: Sumbayev, Vadim V., et al.
Publicado: (2023)

Thapsigargin-Stimulated LAD2 Human Mast Cell Line Is a Potent Cellular Adjuvant for the Maturation of Monocyte-Derived Dendritic Cells for Adoptive Cellular Immunotherapy
por: Taborska, Pavla, et al.
Publicado: (2021)

Types of Dual LAD—Nomenclature confusion!!!
por: Rao, M. Sudhakar
Publicado: (2018)

Mast Cell Accumulation in Glioblastoma with a Potential Role for Stem Cell Factor and Chemokine CXCL12
por: Põlajeva, Jelena, et al.
Publicado: (2011)

Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells
por: Askmyr, M, et al.
Publicado: (2014)

Basic Fibroblast Growth Factor Attenuates Injury in Myocardial Infarction by Enhancing Hypoxia-Inducible Factor-1 Alpha Accumulation
por: Rao, Zhiheng, et al.
Publicado: (2020)

LAD1 expression is associated with the metastatic potential of colorectal cancer cells
por: Moon, Byul, et al.
Publicado: (2020)

Increased number of mast cells in the bone marrow of chronic myeloid leukemia may herald the pending myeloid transformation—the mast cell is an indicator of myeloid transformation
por: Xu, Peipei, et al.
Publicado: (2019)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_carsqoo0qrj21kjmi9vsqrcad4